company background image
ICCC

ImmuCell NasdaqCM:ICCC Stock Report

Last Price

US$7.42

Market Cap

US$57.5m

7D

0.3%

1Y

-7.2%

Updated

01 Feb, 2023

Data

Company Financials

ICCC Stock Overview

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.

ICCC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Risk Analysis

Does not have a meaningful market cap ($58M)


My Notes

New

Notes are coming soon

ImmuCell Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ImmuCell
Historical stock prices
Current Share PriceUS$7.42
52 Week HighUS$10.96
52 Week LowUS$5.98
Beta0.59
1 Month Change21.70%
3 Month Change-5.73%
1 Year Change-7.20%
3 Year Change49.07%
5 Year Change5.30%
Change since IPO642.39%

Recent News & Updates

ImmuCell GAAP EPS of -$0.09, revenue of $3.86M

Aug 11

ImmuCell announces preliminary 2Q sales of $3.9M

Jul 07

Recent updates

Health Check: How Prudently Does ImmuCell (NASDAQ:ICCC) Use Debt?

Sep 15
Health Check: How Prudently Does ImmuCell (NASDAQ:ICCC) Use Debt?

Why We Think Shareholders May Be Considering Bumping Up ImmuCell Corporation's (NASDAQ:ICCC) CEO Compensation

Jun 10
Why We Think Shareholders May Be Considering Bumping Up ImmuCell Corporation's (NASDAQ:ICCC) CEO Compensation

Is ImmuCell (NASDAQ:ICCC) Using Too Much Debt?

Mar 15
Is ImmuCell (NASDAQ:ICCC) Using Too Much Debt?

Does ImmuCell's (NASDAQ:ICCC) Share Price Gain of 38% Match Its Business Performance?

Jan 22
Does ImmuCell's (NASDAQ:ICCC) Share Price Gain of 38% Match Its Business Performance?

Shareholder Returns

ICCCUS BiotechsUS Market
7D0.3%-0.2%1.7%
1Y-7.2%3.9%-12.5%

Return vs Industry: ICCC underperformed the US Biotechs industry which returned 1.2% over the past year.

Return vs Market: ICCC exceeded the US Market which returned -13.6% over the past year.

Price Volatility

Is ICCC's price volatile compared to industry and market?
ICCC volatility
ICCC Average Weekly Movement7.8%
Biotechs Industry Average Movement12.3%
Market Average Movement6.9%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: ICCC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: ICCC's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198268Michael Brighamhttps://immucell.com

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets.

ImmuCell Corporation Fundamentals Summary

How do ImmuCell's earnings and revenue compare to its market cap?
ICCC fundamental statistics
Market CapUS$57.51m
Earnings (TTM)-US$751.80k
Revenue (TTM)US$20.10m

2.9x

P/S Ratio

-76.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ICCC income statement (TTM)
RevenueUS$20.10m
Cost of RevenueUS$10.88m
Gross ProfitUS$9.22m
Other ExpensesUS$9.97m
Earnings-US$751.80k

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 22, 2023

Earnings per share (EPS)-0.097
Gross Margin45.86%
Net Profit Margin-3.74%
Debt/Equity Ratio32.8%

How did ICCC perform over the long term?

See historical performance and comparison